Moderna (MRNA) – The drugmaker has started a study of its Covid 19 vaccine candidate involving adolescents aged twelve to under eighteen. Moderna has dosed the first participant in a study likely to enroll 3,000 individuals which are healthy. Shares of Moderna was downwards 1.3 % contained premarket trading as…